Alopecia is also included in the post-marketing experience sections of the Prescribing Information for Ozempic and Rybelsus, the spokesperson said
No medical, therapeutic, or usage claims are made or implied
1.5-2mg : Noticeable appetite reduction, early fat loss visible on the scale
Mounjaro (Tirzepatide) Mounjaros active ingredient, tirzepatide, is a first-in-class dual GIP and GLP-1 receptor agonist administered via once-weekly subcutaneous injection
Consistent receptor activation means consistent appetite suppression and metabolic effects throughout the week
The right dietary approach can enhance the medication's effectiveness, help manage common side effects, ensure adequate nutrition despite reduced intake, and lay the foundation for maintaining weight loss long-term